蛛网膜下腔出血后长期认知衰退:病理生理、管理与未来方向
本文综述蛛网膜下腔出血后长期认知衰退的病理生理机制,包括早期脑损伤、迟发性脑缺血、神经炎症、表面含铁血黄素沉积和脑积水,并讨论新兴治疗、遗传易感性、管理技术及康复策略,强调需进一步研究靶向治疗和遗传标志物。
要点
- 蛛网膜下腔出血约占所有卒中的5%,幸存者出现长期认知衰退和痴呆风险增加。
- 涉及机制包括早期脑损伤、迟发性脑缺血、神经炎症、表面含铁血黄素沉积和脑积水。
- 新兴治疗针对炎症、铁螯合和微血管功能障碍,遗传易感性与认知结局相关。
核心结论
- 综述强调需进一步研究靶向治疗、遗传标志物和创新方法以预防认知衰退,最终优化蛛网膜下腔出血患者的长期结局。
研究设计与样本
- 综述,检索范围未在原文中报告。
主要发现
- 蛛网膜下腔出血约占所有卒中的5%,幸存者经历长期认知衰退和痴呆风险增加。
- 主要过程包括早期脑损伤、迟发性脑缺血、神经炎症、表面含铁血黄素沉积和脑积水。
- 新兴治疗对减轻炎症、铁螯合和微血管功能障碍等效应显示出前景。
- 遗传易感性与蛛网膜下腔出血后认知结局相关,强调个性化护理策略的作用。
关键数值与推荐
- 管理技术包括血管内弹簧圈栓塞和手术夹闭。
- 康复策略包括增强认知储备和药物干预,以改善幸存者生活质量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Subarachnoid hemorrhage is a critical neurological condition accounting for about 5% of all strokes, and survivors experience long-term cognitive deterioration and increased risk of dementia. The major processes involved in such decline include early brain injury, delayed cerebral ischemia, neuroinflammation, superficial siderosis, and hydrocephalus. These have emerging treatments that offer promise for the mitigation of effects such as inflammation, iron chelation, and microvascular dysfunction. Genetic predispositions have been associated with post-subarachnoid hemorrhage cognitive outcomes and emphasize a role for personalized care strategies. Management techniques reviewed include long-term cognitive health, such as endovascular coiling and surgical clipping. Other rehabilitation strategies that enhance cognitive reserve and pharmacological interventions are discussed about improving the quality of life in survivors. The review highlights the need for further research into targeted therapies, genetic markers, and innovative approaches to prevent cognitive decline, ultimately aiming to optimize long-term outcomes for individuals affected by subarachnoid hemorrhage.
引用
- Aydin S, Peker S. Long-Term Cognitive Decline After Subarachnoid Hemorrhage: Pathophysiology, Management, and Future Directions. Stroke. 2025. PMID: 40035134. doi:10.1161/STROKEAHA.124.049969
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。